Neurocrine Bioscience buy Wedbush
Start price
07.02.25
/
50%
€116.50
Target price
07.02.26
€142.21
Performance (%)
-2.06%
Price
16.01.26
€114.10
Summary
This prediction is currently active. With a performance of -2.06%, the BUY prediction for Neurocrine Bioscience by Wedbush is down slightly. This prediction currently runs until 07.02.26. The prediction end date can be changed by Wedbush at any time. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | -2.228% | -2.228% |
| iShares Core DAX® | 0.191% | 4.892% |
| iShares Nasdaq 100 | -0.614% | 2.901% |
| iShares Nikkei 225® | 0.599% | 7.404% |
| iShares S&P 500 | -0.036% | 3.489% |
Comments by Wedbush for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target lowered by analysts at Wedbush from $157.00 to $147.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Wedbush for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€123.35
31.07.26
31.07.26
-1.00%
16.01.26
16.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.25
16.12.24
16.12.24
€140.81
16.12.25
16.12.25
2.19%
17.12.25
17.12.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€123.80
29.05.24
29.05.24
€140.10
29.05.25
29.05.25
-10.86%
30.05.25
30.05.25
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€107.25
13.09.23
13.09.23
€127.63
13.09.24
13.09.24
-0.05%
14.09.24
14.09.24